Table 2.
Outcomes of ESWL in patients with chronic calcific pancreatitis49.
| Study, year | N | Stone location | ERCP | Complete fragmentation (ductal clearance) | Pain relief: overall (complete relief) | Follow-up, months |
|---|---|---|---|---|---|---|
| Inui et al., 200539 | 555 | NR | 42.7% | 92.4% (72.6%) | 91.1% (NR) | 44.3 m |
| Tadenuma et al., 200541 | 117 | Head (85.5%), Body–tail (14.5%) |
55.6% (55.6%) | 96.6% | 68.2% (NR) | 77.5 ± 30.9 m |
| Seven et al., 201240 | 120 | Head (66.7%), head–body (1.6%), body (2.5%), head–body–tail (29.2%) | 100% | NR | 85% (50%) | 4.3 ± 3.7 years |
| Suzuki et al., 201343 | 479 | NR | 53.2% | 92.1% (74.3%) | 90.8% (NR) | 31.4 m |
| Ohyama et al., 201542 | 128 | Head (76.6%), Body–tail (23.4%) |
100% | NR (51.6%) | 89.9% (NR) | 42.4 ± 35.8 m |
| Hu et al., 201644 | 214 | Head (75.7%), Head–body (6.1%), body (2.3%), head–body–tail (15.9%) | 96.7% | 100% (72.4%) | 95.4% (71.3%) | 18.5 ± 3.3 m |
| Li et al., 201650 | 849 (PC 59) |
Head (23.7%), Head + other location (72.3%), Tail (3.4%) |
PC group: 98.3% | PC group: 100% (67.2%) | 89.1% (63.6%) | 21.9 m |
| Vaysse et al., 201646 | 146 | NR | 73.5% | NR (56.8%) | NR | 23 m |
| Tandan 201947 | 5124 | Head (55.1%) Body (21.4%) Tail (7.4%) Diffuse (15.9%) |
EPS 98% PD stent 69% |
72.6% | 94.5% (82.6%) | 6 m |
Abbreviations: ESWL, extracorporeal shock wave lithotripsy; PD, pancreatic duct; NR, not reported.